Anti-CXCR3/ CD182/ CD183 monoclonal antibody
Anti-CXCR3/ CD182/ CD183 antibody for FACS & in-vivo assay
Go to CXCR3/CXCR3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T25315-Ab-1/ GM-Tg-hg-T25315-Ab-2 | Anti-Human CXCR3 monoclonal antibody | Human |
GM-Tg-rg-T25315-Ab-1/ GM-Tg-rg-T25315-Ab-2 | Anti-Rat CXCR3 monoclonal antibody | Rat |
GM-Tg-mg-T25315-Ab-1/ GM-Tg-mg-T25315-Ab-2 | Anti-Mouse CXCR3 monoclonal antibody | Mouse |
GM-Tg-cynog-T25315-Ab-1/ GM-Tg-cynog-T25315-Ab-2 | Anti-Cynomolgus/ Rhesus macaque CXCR3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T25315-Ab-1/ GM-Tg-felg-T25315-Ab-2 | Anti-Feline CXCR3 monoclonal antibody | Feline |
GM-Tg-cang-T25315-Ab-1/ GM-Tg-cang-T25315-Ab-2 | Anti-Canine CXCR3 monoclonal antibody | Canine |
GM-Tg-bovg-T25315-Ab-1/ GM-Tg-bovg-T25315-Ab-2 | Anti-Bovine CXCR3 monoclonal antibody | Bovine |
GM-Tg-equg-T25315-Ab-1/ GM-Tg-equg-T25315-Ab-2 | Anti-Equine CXCR3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T25315-Ab-1/ GM-Tg-hg-T25315-Ab-2; GM-Tg-rg-T25315-Ab-1/ GM-Tg-rg-T25315-Ab-2; GM-Tg-mg-T25315-Ab-1/ GM-Tg-mg-T25315-Ab-2; GM-Tg-cynog-T25315-Ab-1/ GM-Tg-cynog-T25315-Ab-2; GM-Tg-felg-T25315-Ab-1/ GM-Tg-felg-T25315-Ab-2; GM-Tg-cang-T25315-Ab-1/ GM-Tg-cang-T25315-Ab-2; GM-Tg-bovg-T25315-Ab-1/ GM-Tg-bovg-T25315-Ab-2; GM-Tg-equg-T25315-Ab-1/ GM-Tg-equg-T25315-Ab-2 |
Products Name | Anti-CXCR3 monoclonal antibody |
Format | mab |
Target Name | CXCR3 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-CXCR3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species CXCR3/ CD182/ CD183 VLP (virus-like particle) (Products Developing) |
Cytokine | GM-Tg-g-T25315-Ag-1 | chemokine (C-X-C motif) receptor 3 (CXCR3) protein |
ORF Viral Vector | vGMAP000322 | Human CXCR3 Adenovirus particle |
ORF Viral Vector | pGMAP000322 | Human CXCR3 Adenovirus plasmid |
ORF Viral Vector | pGMLPm002785 | mouse Cxcr3 Lentivirus plasmid |
ORF Viral Vector | vGMLPm002785 | mouse Cxcr3 Lentivirus particle |
Target information
Target ID | GM-T25315 |
Target Name | CXCR3 |
Gene ID | 2833,12766,84475,699438,491952,101094573,497018,100056190 |
Gene Symbol and Synonyms | CD182,CD183,CKR-L2,CMKAR3,CXCR3,GPR9,IP10-R,Mig-R,MigR |
Uniprot Accession | P49682,Q9JII9,Q5KSK8,Q5MD61 |
Uniprot Entry Name | CXCR3_HUMAN,CXCR3_RAT,CXCR3_CANLF,CXCR3_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, Immuno-oncology Target, Cytokine Target |
Disease | Cancer |
Gene Ensembl | ENSG00000186810 |
Target Classification | Checkpoint-Immuno Oncology, GPCR, Tumor-associated antigen (TAA) |
The target: CXCR3, gene name: CXCR3, also named as CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR. This gene encodes a G protein-coupled receptor with selectivity for three chemokines, termed CXCL9/Mig (monokine induced by interferon-g), CXCL10/IP10 (interferon-g-inducible 10 kDa protein) and CXCL11/I-TAC (interferon-inducible T cell a-chemoattractant). Binding of chemokines to this protein induces cellular responses that are involved in leukocyte traffic, most notably integrin activation, cytoskeletal changes and chemotactic migration. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. One of the isoforms (CXCR3-B) shows high affinity binding to chemokine, CXCL4/PF4 (PMID:12782716). [provided by RefSeq, Jun 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.